Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 02 06 2020
revised: 24 09 2020
accepted: 01 10 2020
pubmed: 24 1 2021
medline: 14 8 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

Recent data suggest that multiple sclerosis white matter lesions surrounded by a rim of iron containing microglia, termed iron rim lesions, signify patients with more severe disease course and a propensity to develop progressive multiple sclerosis. So far, however, little is known regarding the dynamics of iron rim lesions over long-time follow-up. In a prospective longitudinal cohort study in 33 patients (17 females; 30 relapsing-remitting, three secondary progressive multiple sclerosis; median age 36.6 years (18.6-62.6), we characterized the evolution of iron rim lesions by MRI at 7 T with annual scanning. The longest follow-up was 7 years in a subgroup of eight patients. Median and mean observation period were 1 (0-7) and 2.9 (±2.6) years, respectively. Images were acquired using a fluid-attenuated inversion recovery sequence fused with iron-sensitive MRI phase data, termed FLAIR-SWI, as well as a magnetization prepared two rapid acquisition gradient echoes, termed MP2RAGE. Volumes and T1 relaxation times of lesions with and without iron rims were assessed by manual segmentation. The pathological substrates of periplaque signal changes outside the iron rims were corroborated by targeted histological analysis on 17 post-mortem cases (10 females; two relapsing-remitting, 13 secondary progressive and two primary progressive multiple sclerosis; median age 66 years (34-88), four of them with available post-mortem 7 T MRI data. We observed 16 nascent iron rim lesions, which mainly formed in relapsing-remitting multiple sclerosis. Iron rim lesion fraction was significantly higher in relapsing-remitting than progressive disease (17.8 versus 7.2%; P < 0.001). In secondary progressive multiple sclerosis only, iron rim lesions showed significantly different volume dynamics (P < 0.034) compared with non-rim lesions, which significantly shrank with time in both relapsing-remitting (P < 0.001) and secondary progressive multiple sclerosis (P < 0.004). The iron rims themselves gradually diminished with time (P < 0.008). Compared with relapsing-remitting multiple sclerosis, iron rim lesions in secondary progressive multiple sclerosis were significantly more destructive than non-iron rim lesions (P < 0.001), reflected by prolonged lesional T1 relaxation times and by progressively increasing changes ascribed to secondary axonal degeneration in the periplaque white matter. Our study for the first time shows that chronic active lesions in multiple sclerosis patients evolve over many years after their initial formation. The dynamics of iron rim lesions thus provide one explanation for progressive brain damage and disability accrual in patients. Their systematic recording might become useful as a tool for predicting disease progression and monitoring treatment in progressive multiple sclerosis.

Identifiants

pubmed: 33484118
pii: 6114694
doi: 10.1093/brain/awaa436
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

833-847

Subventions

Organisme : Austrian Science Fund FWF
ID : KLI 679
Pays : Austria

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Assunta Dal-Bianco (A)

Department of Neurology, Medical University of Vienna, Austria.

Günther Grabner (G)

Department of Neurology, Medical University of Vienna, Austria.
Department of Medical Engineering, Carinthia University of Applied Sciences, Klagenfurt, Austria.

Claudia Kronnerwetter (C)

Biomedical Imaging and Image-guided Therapy, High Field MR Center, Medical University of Vienna, Austria.

Michael Weber (M)

Biomedical Imaging and Image-guided Therapy, High Field MR Center, Medical University of Vienna, Austria.

Barbara Kornek (B)

Department of Neurology, Medical University of Vienna, Austria.

Gregor Kasprian (G)

Biomedical Imaging and Image-guided Therapy, High Field MR Center, Medical University of Vienna, Austria.

Thomas Berger (T)

Department of Neurology, Medical University of Vienna, Austria.

Fritz Leutmezer (F)

Department of Neurology, Medical University of Vienna, Austria.

Paulus Stefan Rommer (PS)

Department of Neurology, Medical University of Vienna, Austria.

Siegfried Trattnig (S)

Biomedical Imaging and Image-guided Therapy, High Field MR Center, Medical University of Vienna, Austria.

Hans Lassmann (H)

Center for Brain Research, Medical University of Vienna, Austria.

Simon Hametner (S)

Department of Neurology, Medical University of Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH